<VariationArchive RecordType="classified" VariationID="206914" VariationName="NM_001165963.4(SCN1A):c.141del (p.Asn47fs)" VariationType="Deletion" Accession="VCV000206914" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-08-06" DateCreated="2015-08-07" MostRecentSubmission="2022-12-31">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="201636" VariationID="206914">
      <GeneList>
        <Gene Symbol="SCN1A" FullName="sodium voltage-gated channel alpha subunit 1" GeneID="6323" HGNC_ID="HGNC:10585" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165984641" stop="166149161" display_start="165984641" display_stop="166149161" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166845669" stop="167005641" display_start="166845669" display_stop="167005641" Strand="-" />
          </Location>
          <OMIM>182389</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN1A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001165963.4(SCN1A):c.141del (p.Asn47fs)</Name>
      <CanonicalSPDI>NC_000002.12:166073480:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="166073481" stop="166073481" display_start="166073481" display_stop="166073481" variantLength="1" positionVCF="166073480" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166929991" stop="166929991" display_start="166929991" display_stop="166929991" variantLength="1" positionVCF="166929990" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>N47fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.166929991del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.166929991del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.166073481del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.166073481del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011906.1" sequenceAccession="NG_011906" sequenceVersion="1" change="g.5159del">
            <Expression>NG_011906.1:g.5159del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001165963.4" sequenceAccession="NM_001165963" sequenceVersion="4" change="c.141del" MANESelect="true">
            <Expression>NM_001165963.4:c.141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159435.1" sequenceAccession="NP_001159435" sequenceVersion="1" change="p.Asn47fs">
            <Expression>NP_001159435.1:p.Asn47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001165964.3" sequenceAccession="NM_001165964" sequenceVersion="3" change="c.141del">
            <Expression>NM_001165964.3:c.141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159436.1" sequenceAccession="NP_001159436" sequenceVersion="1" change="p.Asn47fs">
            <Expression>NP_001159436.1:p.Asn47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001202435.3" sequenceAccession="NM_001202435" sequenceVersion="3" change="c.141del">
            <Expression>NM_001202435.3:c.141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001189364.1" sequenceAccession="NP_001189364" sequenceVersion="1" change="p.Asn47fs">
            <Expression>NP_001189364.1:p.Asn47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353948.2" sequenceAccession="NM_001353948" sequenceVersion="2" change="c.141del">
            <Expression>NM_001353948.2:c.141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340877.1" sequenceAccession="NP_001340877" sequenceVersion="1" change="p.Asn47fs">
            <Expression>NP_001340877.1:p.Asn47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353949.2" sequenceAccession="NM_001353949" sequenceVersion="2" change="c.141del">
            <Expression>NM_001353949.2:c.141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340878.1" sequenceAccession="NP_001340878" sequenceVersion="1" change="p.Asn47fs">
            <Expression>NP_001340878.1:p.Asn47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353950.2" sequenceAccession="NM_001353950" sequenceVersion="2" change="c.141del">
            <Expression>NM_001353950.2:c.141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340879.1" sequenceAccession="NP_001340879" sequenceVersion="1" change="p.Asn47fs">
            <Expression>NP_001340879.1:p.Asn47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353951.2" sequenceAccession="NM_001353951" sequenceVersion="2" change="c.141del">
            <Expression>NM_001353951.2:c.141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340880.1" sequenceAccession="NP_001340880" sequenceVersion="1" change="p.Asn47fs">
            <Expression>NP_001340880.1:p.Asn47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353952.2" sequenceAccession="NM_001353952" sequenceVersion="2" change="c.141del">
            <Expression>NM_001353952.2:c.141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340881.1" sequenceAccession="NP_001340881" sequenceVersion="1" change="p.Asn47fs">
            <Expression>NP_001340881.1:p.Asn47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353954.2" sequenceAccession="NM_001353954" sequenceVersion="2" change="c.141del">
            <Expression>NM_001353954.2:c.141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340883.1" sequenceAccession="NP_001340883" sequenceVersion="1" change="p.Asn47fs">
            <Expression>NP_001340883.1:p.Asn47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353955.2" sequenceAccession="NM_001353955" sequenceVersion="2" change="c.141del">
            <Expression>NM_001353955.2:c.141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340884.1" sequenceAccession="NP_001340884" sequenceVersion="1" change="p.Asn47fs">
            <Expression>NP_001340884.1:p.Asn47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353957.2" sequenceAccession="NM_001353957" sequenceVersion="2" change="c.141del">
            <Expression>NM_001353957.2:c.141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340886.1" sequenceAccession="NP_001340886" sequenceVersion="1" change="p.Asn47fs">
            <Expression>NP_001340886.1:p.Asn47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353958.2" sequenceAccession="NM_001353958" sequenceVersion="2" change="c.141del">
            <Expression>NM_001353958.2:c.141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340887.1" sequenceAccession="NP_001340887" sequenceVersion="1" change="p.Asn47fs">
            <Expression>NP_001340887.1:p.Asn47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353960.2" sequenceAccession="NM_001353960" sequenceVersion="2" change="c.141del">
            <Expression>NM_001353960.2:c.141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340889.1" sequenceAccession="NP_001340889" sequenceVersion="1" change="p.Asn47fs">
            <Expression>NP_001340889.1:p.Asn47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353961.2" sequenceAccession="NM_001353961" sequenceVersion="2" change="c.-2285del">
            <Expression>NM_001353961.2:c.-2285del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006920.6" sequenceAccession="NM_006920" sequenceVersion="6" change="c.141del">
            <Expression>NM_006920.6:c.141del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_008851.3" sequenceAccession="NP_008851" sequenceVersion="3" change="p.Asn47fs">
            <Expression>NP_008851.3:p.Asn47fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_148667.2" sequenceAccession="NR_148667" sequenceVersion="2" change="n.527del">
            <Expression>NR_148667.2:n.527del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_8" sequenceAccession="LRG_8">
            <Expression>LRG_8:g.5159del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA317732" DB="ClinGen" />
        <XRef Type="rs" ID="796053076" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001165963.4(SCN1A):c.141del (p.Asn47fs) AND not provided" Accession="RCV000189056" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2014-08-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001165963.4(SCN1A):c.141del (p.Asn47fs) AND multiple conditions" Accession="RCV002500578" Version="1">
        <ClassifiedConditionList TraitSetID="74739">
          <ClassifiedCondition DB="MedGen" ID="C5543353">Developmental and epileptic encephalopathy 6B</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1858673">Generalized epilepsy with febrile seizures plus, type 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1864987">Migraine, familial hemiplegic, 3</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0751122">Severe myoclonic epilepsy in infancy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-10-29" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-08-07" MostRecentSubmission="2022-12-31">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="74739" Type="TraitChoice" ContributesToAggregateClassification="true">
            <Trait ID="2953" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Migraine, familial hemiplegic, 3</ElementValue>
                <XRef ID="MONDO:0012320" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FHM3</ElementValue>
                <XRef Type="MIM" ID="609634" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10974" />
                <XRef ID="10974" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Familial hemiplegic migraine (FHM) falls within the category of migraine with aura. In migraine with aura (including FHM) the neurologic symptoms of aura are unequivocally localizable to the cerebral cortex or brain stem and include visual disturbance (most common), sensory loss (e.g., numbness or paresthesias of the face or an extremity), and dysphasia (difficulty with speech). FHM must include motor involvement, such as hemiparesis (weakness of an extremity). Hemiparesis occurs with at least one other symptom during FHM aura. Neurologic deficits with FHM attacks can be prolonged for hours to days and may outlast the associated migrainous headache. FHM is often earlier in onset than typical migraine, frequently beginning in the first or second decade; the frequency of attacks tends to decrease with age. Approximately 40%-50% of families with CACNA1A-FHM have cerebellar signs ranging from nystagmus to progressive, usually late-onset mild ataxia.</Attribute>
                <XRef ID="NBK1388" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301562</ID>
                <ID Source="BookShelf">NBK1388</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_HemiplegicMigraine-enPro1031.pdf</URL>
                <CitationText>Orphanet, Hemiplegic Migraine (HM), 2013</CitationText>
              </Citation>
              <XRef ID="569" DB="Orphanet" />
              <XRef ID="C1864987" DB="MedGen" />
              <XRef ID="MONDO:0012320" DB="MONDO" />
              <XRef Type="MIM" ID="609634" DB="OMIM" />
            </Trait>
            <Trait ID="4140" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6A</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe myoclonic epilepsy in infancy</ElementValue>
                <XRef ID="219513" DB="GeneTests" />
                <XRef ID="Dravet+Syndrome/2332" DB="Genetic Alliance" />
                <XRef ID="230437002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 6 (Dravet syndrome)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epilepsy, Myoclonic, Infantile, Severe</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dravet syndrome</ElementValue>
                <XRef ID="MONDO:0100135" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ICE-GTC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DRVT</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SMEI</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SME</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DEE6A</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EIEE6</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">SCN1A seizure disorders encompass a spectrum that ranges from simple febrile seizures and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to Dravet syndrome and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end. Phenotypes with intractable seizures including Dravet syndrome are often associated with cognitive decline. Less commonly observed phenotypes include myoclonic astatic epilepsy (MAE), Lennox-Gastaut syndrome, infantile spasms, epilepsy with focal seizures, and vaccine-related encephalopathy and seizures. The phenotype of SCN1A seizure disorders can vary even within the same family.</Attribute>
                <XRef ID="NBK1318" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301494</ID>
                <ID Source="BookShelf">NBK1318</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_Dravet.pdf</URL>
                <CitationText>Orphanet, Dravet syndrome, 2008</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <Citation Type="Suggested Reading">
                <ID Source="PubMed">28880996</ID>
              </Citation>
              <XRef ID="33069" DB="Orphanet" />
              <XRef ID="C0751122" DB="MedGen" />
              <XRef ID="MONDO:0100135" DB="MONDO" />
              <XRef Type="MIM" ID="607208" DB="OMIM" />
            </Trait>
            <Trait ID="56123" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Developmental and epileptic encephalopathy 6B, non-Dravet</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy 6B</ElementValue>
                <XRef ID="MONDO:0030268" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DEE6B</ElementValue>
                <XRef Type="MIM" ID="619317" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">SCN1A seizure disorders encompass a spectrum that ranges from simple febrile seizures and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to Dravet syndrome and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end. Phenotypes with intractable seizures including Dravet syndrome are often associated with cognitive decline. Less commonly observed phenotypes include myoclonic astatic epilepsy (MAE), Lennox-Gastaut syndrome, infantile spasms, epilepsy with focal seizures, and vaccine-related encephalopathy and seizures. The phenotype of SCN1A seizure disorders can vary even within the same family.</Attribute>
                <XRef ID="NBK1318" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301494</ID>
                <ID Source="BookShelf">NBK1318</ID>
              </Citation>
              <XRef ID="C5543353" DB="MedGen" />
              <XRef ID="MONDO:0030268" DB="MONDO" />
              <XRef Type="MIM" ID="619317" DB="OMIM" />
            </Trait>
            <Trait ID="9389" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GEFS+, TYPE 2</ElementValue>
                <XRef Type="MIM" ID="604403" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Generalized epilepsy with febrile seizures plus, type 2</ElementValue>
                <XRef ID="Generalized+epilepsy+with+febrile+seizures+plus%2C+type+2/8460" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011461" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GEFSP2</ElementValue>
                <XRef Type="MIM" ID="604403" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GEFS+2</ElementValue>
                <XRef Type="MIM" ID="604403" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">SCN1A seizure disorders encompass a spectrum that ranges from simple febrile seizures and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to Dravet syndrome and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end. Phenotypes with intractable seizures including Dravet syndrome are often associated with cognitive decline. Less commonly observed phenotypes include myoclonic astatic epilepsy (MAE), Lennox-Gastaut syndrome, infantile spasms, epilepsy with focal seizures, and vaccine-related encephalopathy and seizures. The phenotype of SCN1A seizure disorders can vary even within the same family.</Attribute>
                <XRef ID="NBK1318" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SCN1A-Related Seizure Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301494</ID>
                <ID Source="BookShelf">NBK1318</ID>
              </Citation>
              <XRef ID="36387" DB="Orphanet" />
              <XRef ID="C1858673" DB="MedGen" />
              <XRef ID="MONDO:0011461" DB="MONDO" />
              <XRef Type="MIM" ID="604403" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="447434" SubmissionDate="2015-07-30" DateLastUpdated="2015-08-07" DateCreated="2015-08-07">
        <ClinVarSubmissionID localKey="54788" />
        <ClinVarAccession Accession="SCV000242687" DateUpdated="2015-08-07" DateCreated="2015-08-07" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-08-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>c.141delT: p.Asn47LysfsX45 (N47KfsX45) in exon 1 of the SCN1A gene (NM_001165963.1). The normal sequence with the base that is deleted in braces is GAAAA{T}GGCC. The c.141delT mutation in the SCN1A gene causes a frameshift starting with codon Asparagine 47, changes this amino acid to a Lysine residue and creates a premature Stop codon at position 45 of the new reading frame, denoted p.Asn47LysfsX45. This mutation is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Although this mutation has not been previously reported to our knowledge, its presence is consistent with a diagnosis of SCN1A-related disorder. The variant is found in INFANT-EPI panel(s).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.N47KfsX45</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001165963.1:c.141delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5464088" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_001165963.3:c.141del|OMIM:604403;607208;609634;619317" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002810540" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="clinic" OrgAbbreviation="FLGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001165963.3:c.141del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604403" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607208" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609634" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="619317" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5464088" TraitType="Disease" MappingType="XRef" MappingValue="607208" MappingRef="OMIM">
        <MedGen CUI="C0751122" Name="Severe myoclonic epilepsy in infancy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5464088" TraitType="Disease" MappingType="XRef" MappingValue="609634" MappingRef="OMIM">
        <MedGen CUI="C1864987" Name="Migraine, familial hemiplegic, 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="447434" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5464088" TraitType="Disease" MappingType="XRef" MappingValue="619317" MappingRef="OMIM">
        <MedGen CUI="C5543353" Name="Developmental and epileptic encephalopathy 6B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5464088" TraitType="Disease" MappingType="XRef" MappingValue="604403" MappingRef="OMIM">
        <MedGen CUI="C1858673" Name="Generalized epilepsy with febrile seizures plus, type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

